Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 AUD | +4.76% | 0.00% | +15.79% |
18/03 | Botanix Pharmaceuticals Limited(ASX:BOT) added to S&P/ASX All Ordinaries Index | CI |
27/02 | Botanix Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 2.75M 1.81M 151M | Sales 2023 | 3.77M 2.48M 207M | Capitalization | 171M 112M 9.34B |
---|---|---|---|---|---|
Net income 2022 | -13M -8.53M -712M | Net income 2023 | -9M -5.91M -493M | EV / Sales 2022 | 17.5 x |
Net cash position 2022 | 7.16M 4.7M 392M | Net cash position 2023 | 10.25M 6.73M 561M | EV / Sales 2023 | 42.5 x |
P/E ratio 2022 |
-4.21
x | P/E ratio 2023 |
-16.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 85.28% |
1 day | +4.76% | ||
Current month | -2.22% | ||
1 month | -6.38% | ||
3 months | +29.41% | ||
6 months | +57.14% | ||
Current year | +15.79% |
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 01/19/01 |
Vincent Ippolito
CHM | Chairman | 65 | 20/19/20 |
Chief Tech/Sci/R&D Officer | 68 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 21/19/21 |
Henry Bosch
BRD | Director/Board Member | - | 01/16/01 |
Vincent Ippolito
CHM | Chairman | 65 | 20/19/20 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.22 | +4.76% | 3 268 674 |
26/24/26 | 0.21 | -2.33% | 1,749,101 |
24/24/24 | 0.215 | 0.00% | 1,530,244 |
23/24/23 | 0.215 | -2.27% | 2,173,258 |
22/24/22 | 0.22 | -2.22% | 1,501,920 |
Delayed Quote Australian S.E., April 29, 2024 at 11:40 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+15.79% | 216M | |
+3.85% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B | |
+3.90% | 1.65B |
- Stock Market
- Equities
- BOT Stock